Literature DB >> 26874666

[Curative pelvic exenteration for recurrent cervical carcinoma in the era of concurrent chemotherapy and radiation therapy. A systematic review].

H Sardain1, V Lavoué2, F Foucher2, J Levêque3.   

Abstract

OBJECTIVE: The purpose of this review is to assess the preoperative management in case of recurrent cervical cancer, to assess patients for a surgical curative treatment.
METHODS: English publications were searched using PubMed and Cochrane Library.
RESULTS: In the purpose of curative surgery, pelvic exenteration required clear margins. Today, only half of pelvic exenteration procedures showed postoperative clear margins. Modern imaging (RMI and Pet-CT) does not allow defining local extension of microcopic disease, and thus postoperative clear margins. Despite the same generic term of pelvic exenteration, there is a wide heterogeneity in surgical procedures in published cohorts.
CONCLUSION: Because clear margins are required for curative pelvic exenteration, but are not predictable by preoperative assessment. The larger surgery, i.e. the infra-elevator exenteration with vulvectomy, could be the logical surgical choice to increase the rate of clear margins and therefore, recurrent cervical carcinoma patient survival.
Copyright © 2016 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Cancer du col de l’utérus; Cervical carcinoma; Exentération pelvienne; Pelvic exenteration; Recurrence; Récurrence

Mesh:

Year:  2016        PMID: 26874666     DOI: 10.1016/j.jgyn.2016.01.004

Source DB:  PubMed          Journal:  J Gynecol Obstet Biol Reprod (Paris)        ISSN: 0150-9918


  2 in total

1.  Survival After Pelvic Exenteration for Cervical Cancer.

Authors:  Imen Bouraoui; Hanen Bouaziz; Nesrine Tounsi; Racha Ben Romdhane; Monia Hechiche; Maher Slimane; Khaled Rahal
Journal:  J Obstet Gynaecol India       Date:  2021-06-11

2.  Pelvic exenteration by robotically-assisted laparoscopy: A feasibility series of 6 cases.

Authors:  Huyên-Thu Nguyen Xuan; Deloménie Myriam; Ngo Charlotte; Douard Richard; Bats Anne-Sophie; Timsit Marc Olivier; Méjean Arnaud; Lécuru Fabrice
Journal:  Gynecol Oncol Rep       Date:  2018-05-29
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.